Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Zydus Lifesciences Limited Press Release Jan 07 2025

· Issued by Zydus Lifesciences Limited via NSE India

Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 07, 2025, titled "Zydus announces agreement with CVS Caremark to add Zituvio TM, Zituvimet TM and Zituvimet TM XR (Sitagliptin Sitagliptin and Metformin Hydrochloride) to its template formulary".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases